Latest filing published 24 May 2023 for ANI Pharmaceuticals INC.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -54.2%Entry US$67.77 · Close at T+365 US$31.06
- -18.3%Entry US$91.85 · Close at T+365 US$75.02
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
David Nash: trading record in brief
Filings by David Nash span 3 companies, the busiest being Endo Pharmaceuticals Holdings Inc, ANI Pharmaceuticals Inc and Humana Inc. Over a trading history stretching from 14 March 2011 to 23 May 2023, the count stands at 16 filings.
The open-market record is one-sided, with 3 purchases worth €112k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 13 share grants.
In size, the median ticket on the buying side is €16k.
The record was last updated on 24 May 2023 with a share grant in ANI Pharmaceuticals Inc. The clock since the last published purchase (29 May 2019) now reads 2,721 days. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to David Nash
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,865 shares0Common StockSEC:0001104659-23-064146:0
- 10,049 shares0Common StockSEC:0001415889-22-004398:0
- 9,292 shares0Common StockSEC:0001415889-21-001656:0
- 7,119 shares0Common StockSEC:0001104659-20-046396:0
- 1,445 shares@ US$68.76100.0% of flowCommon StockSEC:0001144204-19-028634:0Canonical exit: 22 Aug 2019 (T+90)
- 1,991 shares0Common StockSEC:0001144204-19-017413:0
- 1,800 shares0Common StockSEC:0001144204-18-033530:0
- 222 shares0Common Stock, par value, $.01 per shareSEC:0001209191-14-000370:0
- 330 shares0Common Stock, par value, $.01 per shareSEC:0001209191-13-046650:0
- 408 shares0Common Stock, par value, $.01 per shareSEC:0001209191-13-035175:0
- 488 shares0Common Stock, par value, $.01 per shareSEC:0001209191-13-019857:0
- 6,515 shares2010 Stock Incentive Plan Restricted Stock Units (RSU)SEC:0001209191-13-016631:0
- 670 shares@ US$30.80Common Stock, par value, $0.01 per shareSEC:0001209191-13-014691:0Canonical exit: 3 Jun 2013 (T+90)
- 112 shares@ US$87.93Humana CommonSEC:0000049071-12-000064:0Canonical exit: 26 Jun 2012 (T+90)
- 5,481 shares2010 Stock Incentive Plan Restricted Stock Units (RSU)SEC:0001209191-12-018439:0
- 4,260 shares2010 Stock Incentive Plan Restricted Stock Units (RSU)SEC:0001209191-11-018522:0
16 of 16 declarations
